SENS PubMed Publication Search
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease
Acta Neuropathol Commun. 2020 Aug 10;8(1):132. doi: 10.1186/s40478-020-01012-6.
Kathleen M Farmer 1 2, Gaurav Ghag 1 2 3, Nicha Puangmalai 1 2, Mauro Montalbano 1 2, Nemil Bhatt 1 2, Rakez Kayed 4 5
Abstract:
...Here, we show p53 forms oligomers and fibrils in human AD brain, but not control brain. p53 oligomers can also be detected in htau and P301L mouse models. Additionally, we demonstrate that p53 interacts with tau, specifically tau oligomers, in AD brain and can be recapitulated by in vitro exogenous tau oligomer treatment in C57BL/6 primary neurons. p53 oligomers also colocalize, potentially seeding, endogenous p53 in primary neurons. Lastly, we demonstrate that in the presence of DNA damage, phosphorylated p53 is mislocalized outside the nucleus and p53-mediated DNA damage responders are significantly decreased in AD brain. Control brain shows a healthy DNA damage response, indicating a loss of nuclear p53 function in AD may be due to p53 aggregation and/or interactions with tau oligomers. Given the critical role of p53 in cellular physiology, the disruption of this crucial transcription factor may set an irreversible course towards neurodegeneration in AD and potentially other tauopathies, warranting further investigation.
PMID: 32778161
Free Full-Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418370/
Tags: Alzheimer’s, humans, mice, p53, p53 aggregation